Literature DB >> 6361053

Fluorescent-antibody reagents for the identification of Clostridium botulinum.

C Glasby, C L Hatheway.   

Abstract

Fluorescent-antibody reagents were prepared against vegetative cells of representative strains of each physiological group and toxin type of Clostridium botulinum known to have caused botulism in humans. A fluorescent-antibody reagent was also prepared for C. botulinum type G, which has been isolated from autopsy specimens but which has not clearly been implicated in botulism. These fluorescent-antibody reagents were evaluated against 200 strains of C. botulinum and 64 strains of other clostridia. Each reagent reacted with at least a 2+ intensity with all of the strains in its same toxin type and physiological group. Ninety-seven percent of the strains gave at least a 3+ reaction with the homologous group or toxin type reagent. Some cross-reactions occurred with reagents against different toxin type strains within a physiological group; there was less cross-reaction between physiological groups and very little reactivity of C. botulinum reagents with nontoxigenic organisms. Absorption of cross-reacting antibodies was not successful. Certain reagents could be used for presumptive laboratory identification of C. botulinum strains causing botulism, especially in infants. The type G reagent provided a good means of identifying C. botulinum type G, which lacks the lipase marker and whose toxigenicity may be more difficult to demonstrate in mixed cultures. There was a serological relationship between C. botulinum type G and some strains of Clostridium subterminale. This relationship provided evidence of differences between strains of C. botulinum type G isolated in two different countries.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361053      PMCID: PMC272912          DOI: 10.1128/jcm.18.6.1378-1383.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Another type of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

2.  Use of immunofluorescence to identify Clostridium botulinum types A, B, and E.

Authors:  T F Midura; Y Inouye; H L Bodily
Journal:  Public Health Rep       Date:  1967-03       Impact factor: 2.792

3.  Type F infant botulism.

Authors:  R E Hoffman; B J Pincomb; M R Skeels
Journal:  Am J Dis Child       Date:  1982-03

4.  Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths.

Authors:  O Sonnabend; W Sonnabend; R Heinzle; T Sigrist; R Dirnhofer; U Krech
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

5.  Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome.

Authors:  S S Arnon; T F Midura; K Damus; R M Wood; J Chin
Journal:  Lancet       Date:  1978-06-17       Impact factor: 79.321

6.  Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.

Authors:  H M Solomon; R K Lynt; D A Kautter; T Lilly
Journal:  Appl Microbiol       Date:  1971-02
  6 in total
  7 in total

1.  Multilocus enzyme electrophoresis of Clostridium argentinense (Clostridium botulinum toxin type G) and phenotypically similar asaccharolytic clostridia.

Authors:  M Altwegg; C L Hatheway
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

2.  Evaluation of fluorescent-antibody tests as a means of confirming infant botulism.

Authors:  C Glasby; C L Hatheway
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

3.  Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.

Authors:  W F Sonnabend; U P Sonnabend; T Krech
Journal:  Appl Environ Microbiol       Date:  1987-08       Impact factor: 4.792

Review 4.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Selection and Development of Nontoxic Nonproteolytic Clostridium botulinum Surrogate Strains for Food Challenge Testing.

Authors:  Marijke Poortmans; Kristof Vanoirbeek; Martin B Dorner; Chris W Michiels
Journal:  Foods       Date:  2022-05-27

Review 6.  Botulinum toxin: bioweapon & magic drug.

Authors:  Ram Kumar Dhaked; Manglesh Kumar Singh; Padma Singh; Pallavi Gupta
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

7.  A historical and proteomic analysis of botulinum neurotoxin type/G.

Authors:  Rebecca R Terilli; Hercules Moura; Adrian R Woolfitt; Jon Rees; David M Schieltz; John R Barr
Journal:  BMC Microbiol       Date:  2011-10-18       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.